Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rusckowski

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1993
Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo propertiesD J Hnatowich, G Mardirossian, M Rusckowski, et al.
Nuclear Medicine and Biology|October 1, 1996
Technetium-99m antibodies labeled with MAG3 and SHNH: an in vitro and animal in vivo comparisonK Lei, M Rusckowski, F Chang, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
New indium-111 labeled biotin derivatives for improved immunotargetingF Virzi, B Fritz, M Rusckowski, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 23, 2002
The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in miceG Liu, S Zhang, J He, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNAY M Zhang, Y Wang, N Liu, et al.
Nuclear Medicine and Biology|August 24, 2001
A novel and simplified route to the synthesis of N3S chelators for 99mTc labelingZ Zhu, Y Wang, Y Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycineD J Hnatowich, T Qu, F Chang, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 20, 2010
Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effectorG Liu, S Dou, P H Pretorius, et al.
American Journal of Physiologic Imaging|January 1, 1990
Pharmacokinetic modeling of radiolabeled antibody distribution in manA Rescigno, H Bushe, A B Brill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA)G Mardirossian, K Lei, M Rusckowski, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1993
Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo propertiesD J Hnatowich, G Mardirossian, M Rusckowski, et al.
Nuclear Medicine and Biology|October 1, 1996
Technetium-99m antibodies labeled with MAG3 and SHNH: an in vitro and animal in vivo comparisonK Lei, M Rusckowski, F Chang, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
New indium-111 labeled biotin derivatives for improved immunotargetingF Virzi, B Fritz, M Rusckowski, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 23, 2002
The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in miceG Liu, S Zhang, J He, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNAY M Zhang, Y Wang, N Liu, et al.
Nuclear Medicine and Biology|August 24, 2001
A novel and simplified route to the synthesis of N3S chelators for 99mTc labelingZ Zhu, Y Wang, Y Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycineD J Hnatowich, T Qu, F Chang, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 20, 2010
Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effectorG Liu, S Dou, P H Pretorius, et al.
American Journal of Physiologic Imaging|January 1, 1990
Pharmacokinetic modeling of radiolabeled antibody distribution in manA Rescigno, H Bushe, A B Brill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA)G Mardirossian, K Lei, M Rusckowski, et al.
Pageof 6